Filter By Industry
Filter By Tag

Newsroom

AbVision Inc Press releases

1 - 1 of 1 Press Release

BioSuperior™ Anti-CD47 Bispecific Antibody from Abvision Inc
Dec 24, 2020
AbVision, Inc., an innovative biopharmaceutical company, has developed two novel bispecific therapeutic antibody candidates: AVI-525B and AVI-535B, powered by its SpeedyAb™ technology platform of therapeutic antibody.


AbVision Inc RSS Feed